Company Name: Immuron Ltd

Immuron Ltd is a clinical stage biopharmaceutical company.  The company is engaged in the development of immunomodulator polyclonal antibodies.  The company’s pipeline includes product candidates for Non Alcoholic Steatohepatitis (NASH) and C. difficile.

Ticker Symbol: IMRN (NASDAQ)

Company Website: http://www.immuron.com

Social Media:

Immuron Ltd Linkedin

Headquarters: Armadale, Victoria, Australia